Trial Profile
Home Administration Of Nivestim(tm) In The Primary Prophylaxis Of Chemotherapy- Induced Febrile Neutropenia Non-interventional, Observational, Prospective Study Short Name: Home Short Name: Home
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary)
- Indications Chemotherapy induced febrile neutropenia
- Focus Therapeutic Use
- Acronyms Home
- Sponsors Pfizer
- 14 Mar 2017 Status changed from recruiting to completed.
- 10 Nov 2016 New trial record